Michael Scolaro

Michael Scolaro

Nov 19, 2017

Group 6 Copy 232
-8
Please wait...

About This Project

We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

Blast off!

Browse Other Projects on Experiment

Related Projects

Help us pioneer stem cell therapy for giraffe!

Arthritis is common in geriatric giraffe. Cheyenne Mountain Zoo is uniquely suited to help find better arthritis...

Can a Dietary Intervention Reduce Mercury Toxicity Among Native Communities in Peru?

A state of emergency has been declared in Madre de Dios, Peru due to high levels of mercury (Hg) exposure...

Managing Congenital Adrenal Hyperplasia in the Amish Population

Congenital adrenal hyperplasia (CAH) is a disorder that affects the production of hormones critical for...

Backer Badge Funded